Chronic Obstructive Pulmonary Disease News and Research

Latest Chronic Obstructive Pulmonary Disease News and Research

High pneumonia incidence ups elderly COPD medical costs

Older individuals with chronic obstructive pulmonary disease are almost six times more likely to develop pneumonia and eight times more likely to need hospital treatment than those without the disease, US researchers have found.

5 Nov 2013

FDA approves Prior Approval Supplement for EMBEDA Extended Release Capsules CII

Pfizer Inc. announced today that the U.S. Food and Drug Administration has approved a Prior Approval Supplement for EMBEDA (morphine sulfate and naltrexone hydrochloride) Extended Release Capsules CII.

4 Nov 2013

Farmyard proximity benefit to respiratory health

Data from the Netherlands indicate that living in close proximity to livestock farms is associated with decreased respiratory morbidity, including asthma, allergic rhinitis, and chronic obstructive pulmonary disease.

30 Oct 2013

Active management boosts patient satisfaction with COPD care

A disease management program for chronic obstructive pulmonary disease based on the Chronic Care Model leads to greater patient satisfaction with care than standard disease management, a randomized trial suggests.

30 Oct 2013

Once-daily prescription medicine for COPD now available throughout the U.S.

GlaxoSmithKline plc and Theravance, Inc. today announced that BREO ELLIPTA, a once-daily prescription medicine for chronic obstructive pulmonary disease, is now available to pharmacies throughout the U.S.

30 Oct 2013

Reduce tobacco consumption, reduce childhood asthma

A scientific study recently published on International Journal of Statistics in Medical Research states that tobacco consumption must be decreased by 15% in Spain, particularly at home, in order to reduce the number of childhood asthma cases.

30 Oct 2013

COMMONWELL project established to support health and social care services

Across Europe, providing health and social care services is becoming increasingly complex and costly. An aging population, a multitude of public, private and informal actors, together with a myriad of e-health systems and technologies create numerous hurdles to offering efficient and cost-effective care.

30 Oct 2013

Pulmatrix reports positive results from initial PUR0200 Phase IB clinical study in COPD

Pulmatrix today announced the successful completion and positive results of the first part of a two-part Phase IB clinical study in chronic obstructive pulmonary disease (COPD) patients with their lead clinical candidate PUR0200.

29 Oct 2013

COPD–asthma overlap heightens exacerbation risk

Patients with chronic obstructive pulmonary disease and concomitant asthma have significantly more exacerbations and hospitalizations than patients with COPD alone, research shows.

28 Oct 2013

COPD telemonitoring ‘costly and ineffective’

Results of a UK-based study indicate that telemonitoring adds little benefit to the self-management of chronic obstructive pulmonary disease.

25 Oct 2013

Scientists develop new drug to treat obstructive airway diseases

Scientists have developed a new drug (RPL554) that could treat obstructive airway diseases such as asthma and chronic obstructive pulmonary disease in two ways at once, according to new research published in The Lancet Respiratory Medicine.

25 Oct 2013

FDA to phase out all inhaler medical products containing CFCs by Dec. 31

The U.S. Food and Drug Administration will complete its phase-out of all inhaler medical products containing chlorofluorocarbons by Dec. 31, 2013. This effort is to comply with an international treaty to protect the ozone layer by phasing out the worldwide production of numerous substances, including CFCs, which contribute to ozone depletion.

24 Oct 2013

COPD treatments: an interview with Professor Price, University of Aberdeen

The first thing is that we can’t cure COPD. The problem we have with COPD is that the process itself is not treatable, certainly not once it gets to the extent that it’s advanced.

22 Oct 2013

Clinical trials will help to develop treatment and follow-up of COPD patients

Three major clinical trials will help to develop and target treatment and follow-up of patients suffering from COPD, lung cancer and rheumatoid arthritis in Norway.

22 Oct 2013

Twitch mouth pressure reflects COPD disease severity

Researchers from China have shown that a non-invasive method of measuring inspiratory muscle strength accurately reflects the severity of chronic obstructive pulmonary disease.

21 Oct 2013

COPD investigational treatments: an interview with Dr. Tunde Otulana, Senior Vice President, Clinical Development and Medical Affairs, Boehringer Ingelheim Pharmaceuticals, Inc.

Olodaterol is a long-acting beta2-agonist (LABA) bronchodilator delivered via the Respimat® inhaler. It is being investigated as a once daily maintenance bronchodilator treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema.

21 Oct 2013

Oral nutritional supplements linked with decreased probability of 30-day hospital readmission

In the U.S., one in five Medicare patients is readmitted to a hospital each year at an estimated cost of $17.5 billion annually.i To reduce this impact, the Affordable Care Act (ACA) has introduced hospital penalties based on readmissions conditions that commonly affect patients aged 65 and older - including acute myocardial infarction, congestive heart failure and pneumonia.

19 Oct 2013